Different types of atrial fibrillation, renal function, and mortality in elderly Chinese patients with coronary

Shihui Fu1, Tao Liu2, Leiming Luo1

  • 1Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.

Insights

In elderly patients with coronary artery disease, permanent atrial fibrillation (AF) is linked to chronic kidney disease (CKD). Paroxysmal AF increases mortality risk in CKD patients, but not in those without CKD.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Background:

  • Atrial fibrillation (AF) and chronic kidney disease (CKD) are common in aging populations and share mortality risks.
  • The interplay between AF types, CKD, and mortality is unclear, particularly in elderly Chinese patients with coronary artery disease.

Purpose of the Study:

  • To investigate the association between different types of atrial fibrillation (AF) and chronic kidney disease (CKD) in elderly patients with coronary artery disease.
  • To determine the impact of AF and CKD on all-cause mortality in this specific patient cohort.

Main Methods:

  • A cohort of 1,050 elderly patients (median age 86 years) with coronary artery disease was studied.
  • Patients were categorized by AF type (paroxysmal, persistent, permanent) and CKD status.
  • All-cause mortality was recorded over a mean follow-up of 417 days.

Main Results:

  • Permanent AF was associated with a higher prevalence of CKD and lower estimated glomerular filtration rate.
  • Mortality was significantly higher in CKD patients with AF compared to those without AF.
  • In CKD patients, paroxysmal AF independently predicted higher mortality, while other AF types did not.

Conclusions:

  • Permanent AF is linked to increased CKD prevalence and reduced kidney function.
  • Paroxysmal AF is an independent mortality risk factor specifically in CKD patients.
  • Understanding AF type is crucial for risk stratification in elderly patients with CKD and coronary artery disease.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
587